Annual Current Ratio
7.04
-9.86-58.34%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual current ratio is 7.04, with the most recent change of -9.86 (-58.34%) on December 31, 2023.
- During the last 3 years, AVTE annual current ratio has risen by +4.40 (+166.67%).
- AVTE annual current ratio is now -89.70% below its all-time high of 68.37, reached on December 31, 2021.
Performance
AVTE Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
8.78
+2.27+34.87%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly current ratio is 8.78, with the most recent change of +2.27 (+34.87%) on September 30, 2024.
- Over the past year, AVTE quarterly current ratio has increased by +1.74 (+24.72%).
- AVTE quarterly current ratio is now -87.16% below its all-time high of 68.37, reached on December 31, 2021.
Performance
AVTE Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
AVTE Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.3% | +24.7% |
| 3 y3 years | +166.7% | +24.7% |
| 5 y5 years | +31.6% | +24.7% |
AVTE Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.7% | at low | -87.2% | +34.9% |
| 5 y | 5-year | -89.7% | +166.7% | -87.2% | +232.6% |
| alltime | all time | -89.7% | +166.7% | -87.2% | +232.6% |
Aerovate Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 8.78(+34.9%) |
| Jun 2024 | - | 6.51(-2.1%) |
| Mar 2024 | - | 6.65(-5.5%) |
| Dec 2023 | 7.04(-58.3%) | 7.04(-24.6%) |
| Sep 2023 | - | 9.34(-18.6%) |
| Jun 2023 | - | 11.48(+1.3%) |
| Mar 2023 | - | 11.33(-33.0%) |
| Dec 2022 | 16.90 | 16.90(-10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 18.84(-53.9%) |
| Jun 2022 | - | 40.85(+15.8%) |
| Mar 2022 | - | 35.27(-48.4%) |
| Dec 2021 | 68.37(+2489.8%) | 68.37(+42.8%) |
| Sep 2021 | - | 47.87(+238.5%) |
| Jun 2021 | - | 14.14(+162.3%) |
| Mar 2021 | - | 5.39(+104.2%) |
| Dec 2020 | 2.64(-50.7%) | 2.64 |
| Dec 2019 | 5.35 | - |
FAQ
- What is Aerovate Therapeutics annual current ratio?
- What is the all time high annual current ratio for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual current ratio year-on-year change?
- What is Aerovate Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly current ratio year-on-year change?
What is Aerovate Therapeutics annual current ratio?
The current annual current ratio of AVTE is 7.04
What is the all time high annual current ratio for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual current ratio is 68.37
What is Aerovate Therapeutics annual current ratio year-on-year change?
Over the past year, AVTE annual current ratio has changed by -9.86 (-58.34%)
What is Aerovate Therapeutics quarterly current ratio?
The current quarterly current ratio of AVTE is 8.78
What is the all time high quarterly current ratio for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly current ratio is 68.37
What is Aerovate Therapeutics quarterly current ratio year-on-year change?
Over the past year, AVTE quarterly current ratio has changed by +1.74 (+24.72%)